Using the Chronic Kidney Disease Guidelines to Evaluate the Renal Safety of Tenofovir Disoproxil Fumarate in Hepatitis B Patients
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14682
Full Text
Open PDFAbstract
Available in full text
Date
April 25, 2018
Authors
Publisher
Wiley